Consoldiated Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Aug. 31, 2015	Aug. 31, 2014	Aug. 31, 2015	Aug. 31, 2014
Income Statement [Abstract]
Revenues	$ 295,084	$ 27,578	$ 296,905	$ 478,593
Related party revenue	5,000		70,000
Total Revenues	300,084	27,578	366,905	478,593
Costs and expenses:
Cost of revenues	184,209	31,101	196,434	268,590
Selling, general and administrative	234,674	164,846	402,640	844,184
Total costs and expenses	418,883	195,947	599,074	1,112,774
Loss from operations	(118,799)	(168,369)	(232,169)	(634,181)
Other income (expense):
Interest expense	$ (319,085)	(375,432)	(908,402)	(1,193,984)
Amortization of deferred finance costs		$ (22,967)	(5,305)	(65,692)
Gain on troubled debt restructuring			$ 2,065,614
Gain on sale of subsidiary				640,180
Gain on settlement of derivative liabilities	$ 265,002	$ 56,679	$ 1,488,450	300,686
Other income (expense)	222		222	56,679
Gain (loss) on change in derivative liabilities	693,360	$ 407,153	(2,324,101)	451,091
Total other income (expense)	639,499	65,433	316,478	188,960
Net income (loss)	520,700	$ (102,936)	84,309	$ (445,221)
Loss from noncontrolling interest	(62,628)		(58,663)
Net income (loss) attributable to Pervasip Corp.	583,328	$ (102,936)	142,972	$ (445,221)
Accretion of preferred stock dividends - beneficial conversion feature	12,030		100,000
Net income (loss) attributable to common stockholders	$ 571,298	$ (102,936)	$ 42,972	$ (445,221)
Basic earnings (loss) per share	$ 0.00	$ (0.00)	$ (0.00)	$ (0.00)
Diluted earnings (loss) per share	$ 0.00	$ (0.00)	$ (0.00)	$ (0.00)
Weighted average number of common shares outstanding: Basic	3,795,760,513	1,007,549,997	2,897,604,470	967,371,815
Weighted average number of common shares outstanding: Diluted	3,795,760,513	1,007,549,997	10,977,588,597	967,371,815